Home / Health / UK Lacks Prostate Screening for High-Risk Groups
UK Lacks Prostate Screening for High-Risk Groups
8 Mar
Summary
- Black men are twice as likely to develop prostate cancer.
- Cancers in black men tend to be more aggressive.
- UK screening lacks inclusion for high-risk groups like black men.
Prostate cancer disproportionately affects black men, who are twice as likely to develop the disease compared to the general population. Furthermore, their cancers often present as more aggressive, with treatment efficacy potentially reduced due to limited involvement in clinical trials. This lack of representation means treatments may be less effective for these groups.
Maurice Blake, a 52-year-old from Manchester, was diagnosed three years ago and is now campaigning to raise awareness about these health disparities. He emphasizes the need for active involvement and a national screening process.
Prostate cancer is the most common cancer in UK men, with over 63,000 diagnoses annually and more than 12,000 deaths. While men over 50 can request a PSA test, a national screening program for asymptomatic individuals is absent.
Recent recommendations from the UK's National Screening Committee propose screening only for a small group with a BRCA gene variant, excluding other high-risk categories such as black men and those with a family history. This decision has drawn criticism, with individuals like Tony Collier, diagnosed with incurable prostate cancer, regretting the absence of early screening.
The committee's final recommendations are expected soon. The call for a comprehensive screening program remains urgent to reduce the annual toll of over 12,000 lives lost to this disease.
